))
Dealing with Rare and Orphan Diseases:The Technology Imperative
Manage episode 343566850 series 3336026
Content provided by Dean Anand. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dean Anand or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Future of Humanity, we will be talking about Rare Diseases with Dr. Vijay Chandru, the Founder and Executive-Chairman of Strand Life Sciences based in Bangalore, India.
The fact is that very few people, mostly children, get these diseases due primarily to random faulty genes. Given that the market size is small, pharmaceutical companies do not always focus on finding a cure; hence they are sometimes called "orphan" diseases. Even when one finds a cure, the cost to the patients and their families could be prohibitive.
Professor Chandru and I will be talking about the different technological interventions that are being pursued across the world to deal with this difficult health issue, and the prognosis for success.
17 episodes
Share
